Kim, Hyori <br/><br/>
Preclinical development of a humanized neutralizing antibody targeting HGF.  [electronic resource] 

 -  Experimental & molecular medicine  03 2017 
 - e309 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2092-6413 
<br/><br/><label>Standard No.: </label>10.1038/emm.2017.21  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Antibodies, Neutralizing--adverse effects<br/>Antineoplastic Agents, Immunological--adverse effects<br/>Brain Neoplasms--drug therapy<br/>Dogs<br/>Female<br/>Glioblastoma--drug therapy<br/>Hep G2 Cells<br/>Hepatocyte Growth Factor--antagonists & inhibitors<br/>Humans<br/>Macaca fascicularis<br/>Madin Darby Canine Kidney Cells<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Proto-Oncogene Proteins c-met--antagonists & inhibitors